A record of what Ankush Bajaj said publicly, with the source. Not advice.
“Bullish on Torrent Pharmaceuticals Ltd, recommending a buy at ₹3,561.00 with a stop loss at ₹3,543.00 and a target price of ₹3,596.00. The stock shows steady strength near recent highs with bullish momentum, confirmed by positive daily technical indicators like RSI and MACD, suggesting a continuation of the uptrend.”
Ankush Bajaj’s track record (trackable calls only): 473 graded calls · 95% CI 39–48%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
Entry: ₹3,561, as stated.
Target ₹3,596, stop ₹3,543, as stated.
No time frame is stated, so it is tracked until a close reaches ₹3,596 or ₹3,543: there is no fixed window.
The target ₹3,596 was reached on a close before the stop ₹3,543. Hit.
The grader’s working: R3 TRADE_SETUP: entered ₹3561 on 2025-09-30 (stated entry ₹3561, LEVEL_CMP entry, filled); target ₹3596 reached at close ₹3603.2 on 2025-09-30. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
How it played out
How this is worked out- Target or stop first
- The target was reached on a close before the stop was.
- Time to target
- The target was reached on a close on the entry session itself.
- Worst close against it
- No close was ever against the call before the target was reached. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.